New Directions in Chronic Myelogenous Leukemia
This information was originally presented on March 17, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.
The goal of this activity is to provide participants with increased knowledge regarding the treatment of patients with chronic myelogenous leukemia (CML).
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other healthcare professionals who manage patients with CML.
Following this activity, participants should be able to:
- Describe the current treatment options approved for the management of patients with CML
- Identify the rationale and need for the development of more effective treatment options both in the first-line and second-line setting for patients with CML
- Review the clinical evidence from ongoing trials evaluating novel treatment options and the potential role of new agents in treatment of CML
Javier Pinilla-Ibarz, MD, PhD
Moffitt Cancer Center
- 0.75 Participation
- 0.85 Nurse
- 0.75 Pharmacist
- 0.75 Physician
In order to view this activity, you will need to have sound playback capabilities and the latest version of Adobe Flash Player installed on your system. Some corporate firewalls may block streaming media traffic. Please be sure you are capable of receiving streaming Flash media (RTMP) traffic.